Page 2 - Alise Reicin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alise reicin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alise Reicin Today - Breaking & Trending Today

Webinar Series to Support Women R&D Leadership in Biotech Announced

Webinar Series to Support Women R&D Leadership in Biotech Announced
Share Article
The Conference Forum announced a new four-part webinar series to support women R&D leadership in biotech from May 12 through August 26, 2021, virtually.
“We are delighted to bring this webinar series to help support women R&D leaders in biotech and to encourage greater equity in biotech leadership,” Valerie Bowling, Executive Director, the Conference Forum.
NEW YORK (PRWEB)
April 23, 2021
The Conference Forum announced a new four-part webinar series to support women R&D leadership in biotech from May 12 through August 26, 2021, virtually.
The first webinar will address navigating unconscious bias in the workplace. Panelists Ramani Varanasi of X-Biotix Therapeutics, Patricia Kitchen of Ocular Therapeutics, Dr Alison Schechter of Axcella, and Laurie Halloran of Halloran Consulting Group will discuss the ....

Priti Hegde , Shannon Turley , Laurie Halloran , Valerie Bowling , Andrew Goldstein , Pearl Huang , Julie Hambleton , Alise Reicin , Alison Schechter , Julie Krop , Foundation Medicine , Conference Forum , Halloran Consulting Group , Executive Director , Ramani Varanasi , X Biotix Therapeutics , Patricia Kitchen , Ocular Therapeutics , Freeline Therapeutics , Sophia Davis , Caroline Stout , Tectonic Therapeutic , பிரிட்டி ஹெக்டே , லாரி ஹாலோரன் , வலேரி பந்துவீச்சு , ஆண்ட்ரூ கோல்ட்ஸ்டைன் ,

Sana Biotechnology Announces Appointments to its Board of Directors

Sana Biotechnology Announces Appointments to its Board of Directors
Josh Bilenker, M.D., Alise Reicin, M.D., and Michelle Seitz, CFA, join Sana Board of Directors
News provided by
Share this article
Share this article
SEATTLE, Jan. 8, 2021 /PRNewswire/ Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines, announced today that Josh Bilenker, M.D., Alise Reicin, M.D., and Michelle Seitz, CFA, have been appointed to the Sana Board of Directors.
Josh, Alise, and Michelle all share a passion and commitment to our long-term vision of engineering cells to make medicines that improve the lives of patients, said Sana President and CEO Steve Harr. The diversity of their experiences, backgrounds, and expertise will be critical to our strategy, decision-making, risk-management, and governance. I look forward to working with them to continue to build Sana. ....

United Kingdom , United States , Alise Reicin , Josh Bilenker , Michelle Seitz , Steve Harr , Eli Lilly , William Blair , Prnewswire Sana Biotechnology Inc , Global Clinical Development At Celgene Corporation , Loxo Oncology Inc , Head Of Global Clinical Development , Health Sciences , Barnard College Of Columbia University , Tectonic Therapeutic Inc , Financial Accounting Foundation , Sana Biotechnology Inc , Massachusetts Institute Of Technology , Princeton University , Drug Administration , Johns Hopkins University School Of Medicine , Harvard Medical School , Aisling Capital , Dean Council , Indiana University Kelley School Of Business , Columbia Medical School ,